Patients with breast cancer receiving antibody-drug conjugates after chemo can generally expect milder side effects compared with their previous treatment.
Kelsey Martin
Advertisement
Articles by Kelsey Martin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
What the FDA Approval of Inluriyo Means for Patients With Breast Cancer
2
FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer
3
What Subcutaneous Keytruda Means for Patients With Melanoma
4
Early Detection and Misconceptions in Lung Cancer
5
